LabCorp Extends Agreement with UnitedHealthcare Read more about LabCorp Extends Agreement with UnitedHealthcare
LabCorp is Scheduled to Present at the Bank of America Merrill Lynch Global Healthcare Conference Read more about LabCorp is Scheduled to Present at the Bank of America Merrill Lynch Global Healthcare Conference
LabCorp Introduces HCV Resistance Testing through Monogram Biosciences with the Launch of HCV GenoSure(R) NS3/4A Read more about LabCorp Introduces HCV Resistance Testing through Monogram Biosciences with the Launch of HCV GenoSure(R) NS3/4A
LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc. Read more about LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc.
Laboratory Corporation of America(R) Holdings Announces Commencement of Offer to Purchase Its Zero Coupon Convertible Subordinated Notes Due 2021 Read more about Laboratory Corporation of America(R) Holdings Announces Commencement of Offer to Purchase Its Zero Coupon Convertible Subordinated Notes Due 2021
LabCorp Clinical Trials Announces Strategic Alliance with David H. Murdock Research Institute to Offer Specialized Biomarker and Assay Development Services Read more about LabCorp Clinical Trials Announces Strategic Alliance with David H. Murdock Research Institute to Offer Specialized Biomarker and Assay Development Services
Laboratory Corporation of America(R) Holdings Announces Second Quarter 2011 Results Read more about Laboratory Corporation of America(R) Holdings Announces Second Quarter 2011 Results
LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc. Read more about LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc.
Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 Read more about Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021
LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc. Read more about LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc.
